- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
ifa Systems acquires inoveon
ifa Systems AG has acquired inoveon Corp. ifa Systems provides ophthalmology-related software applications, including an electronic health record system that has been adopted in Europe and Latin America and now has been introduced into the North American and Asian markets. inoveon Corp. is a medical services company focused on managing diabetic eye disease, clinical research, and development.
Oklahoma City, OK-ifa Systems AG has acquired inoveon Corp.
ifa Systems provides ophthalmology-related software applications, including an electronic health record system that has been adopted in Europe and Latin America and now has been introduced into the North American and Asian markets. inoveon Corp. is a medical services company focused on managing diabetic eye disease, clinical research, and development.
The two companies previously have collaborated in developing open clinical and health information technology standards. The merger is expected to broaden ifa’s product line and distribution structure and further its international market share in 17 countries managing more than 70 million patients’ data.
The merger also means that Oklahoma City will become a hub for international telemedicine activities for inoveon, including service development and consulting activities. The inoveon platform will be extended, and its services will expand to include new ones for ifa’s installed client base.
